Literature DB >> 11223733

Hospital charges attributable to bronchoscopy-related complications in outpatients.

H G Colt1, T Matsuo.   

Abstract

BACKGROUND: Despite literature pertaining to algorithms of care, operating room charges and other financial management issues in medicine, there is a paucity of data pertaining to the fiscal consequences of bronchoscopic practice.
OBJECTIVE: To identify hospital charges directly attributable to bronchoscopy-related complications in outpatients.
METHODS: A prospective analysis of outpatient bronchoscopy-related complications, clinical outcomes and hospital charges resulting directly from procedure-related adverse events in 660 consecutive outpatients undergoing flexible fiberoptic bronchoscopy (FFB) during a period of 30 consecutive months at the University of California, San Diego Medical Center, was performed.
RESULTS: Altogether, 1,009 consecutive outpatient FFBs were performed on 660 patients (mean age 58 years, range 16-91 years). Fifty adverse events (5% of all procedures) occurred in 44 patients. These were bronchospasm (31 cases), hemoptysis (5 cases), pneumothorax (3 cases), nausea/vomiting (3 cases), hypoxemia (2 cases), seizure (2 cases), laryngeal spasm (2 cases), chills/fever (1 case) and a vasovagal episode (1 case). Prolonged length of stay in the postprocedure recovery area on 22 occasions (2.2% of all procedures) resulted in USD 6,996 in additional hospital charges. Hospitalization was necessary in only 5 instances (0.5% of all procedures), but resulted in USD 34,500 in additional charges (range for the 5 patients, USD 2,000-11,000) that were directly attributable to a procedure-related complication.
CONCLUSION: Hospital charges directly attributable to outpatient flexible bronchoscopy-related complications are minimal, but escalate considerably if hospitalization becomes necessary. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2001        PMID: 11223733     DOI: 10.1159/000050465

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  5 in total

1.  A multicenter pilot study of a bronchial valve for the treatment of severe emphysema.

Authors:  D H Sterman; A C Mehta; D E Wood; P N Mathur; R J McKenna; D E Ost; J D Truwit; P Diaz; M M Wahidi; R Cerfolio; R Maxfield; A I Musani; T Gildea; F Sheski; M Machuzak; A R Haas; H X Gonzalez; S C Springmeyer
Journal:  Respiration       Date:  2009-11-17       Impact factor: 3.580

2.  Diagnosis of second primary tumor and long-term survival after single initial triple endoscopy in patients with head and neck cancer.

Authors:  Antonio Vitor Martins Priante; Jefferson Luiz Gross; Claudia Zitron Sztokfisz; Inês Nobuko Nishimoto; Luiz Paulo Kowalski
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-10-18       Impact factor: 2.503

3.  Outcomes of a Clinical Pathway for Pleural Disease Management: "Pleural Pathway".

Authors:  Srinivas R Mummadi; Peter Y Hahn
Journal:  Pulm Med       Date:  2018-04-01

4.  Early complications in flexible bronchoscopy at a university hospital.

Authors:  Marcia Jacomelli; Stephania Silva Margotto; Sergio Eduardo Demarzo; Paulo Rogério Scordamaglio; Paulo Francisco Guerreiro Cardoso; Addy Lidvina Mejia Palomino; Viviane Rossi Figueiredo
Journal:  J Bras Pneumol       Date:  2020-06-01       Impact factor: 2.624

5.  Value of oesophagoscopy and bronchoscopy in diagnosis of synchronous malignancies in patients with head and neck squamous cell carcinomas.

Authors:  Shi Yeung Ho; Raymond King Yin Tsang
Journal:  BMC Cancer       Date:  2020-12-01       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.